SKI Market

Indian Indices

Sensex

83,739.13 2,072.67
( 2.54%)

Global Indices

Nasdaq

49,433.27 519.79
(1.06%)

Dow Jones

6,997.90 37.87
(0.54%)

Hang Seng

54,706.11 2,050.93
(3.90%)

Nikkei 225

10,322.91 99.37
(0.97%)

Forex

USD-INR

91.61 -0.04
(-0.05%)

EUR-INR

108.55 -0.05
(-0.05%)

GBP-INR

125.35 -0.06
(-0.05%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astal Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

512600

INE307N01014

76.88845

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

34.25

339.75

EPS(TTM)

Face Value()

Div & Yield %

2.35

Back

Apis India consolidated net profit rises 5.51% in the September 2025 quarter

Nov 15,2025

Net profit of Apis India rose 5.51% to Rs 7.08 crore in the quarter ended September 2025 as against Rs 6.71 crore during the previous quarter ended September 2024. Sales rose 19.67% to Rs 96.25 crore in the quarter ended September 2025 as against Rs 80.43 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	96.25	80.43	20
OPM %	11.49	11.09	-
PBDT	10.64	7.70	38
PBT	9.46	7.05	34
NP	7.08	6.71	6

83,739.13 2,072.67 ( 2.54%)

49,433.27 519.79 (1.06%)

6,997.90 37.87 (0.54%)

54,706.11 2,050.93 (3.90%)

10,322.91 99.37 (0.97%)

91.61 -0.04 (-0.05%)

108.55 -0.05 (-0.05%)

125.35 -0.06 (-0.05%)

0.59 0.00 (-0.07%)